Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study of Tremelimumab Plus Durvalumab Combination With or Without Radiation in Relapsed Small Cell Lung Cancer

NCT02701400 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT02701400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02701400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study of Tremelimumab Plus Durvalumab Combination With or Without Radiation in Relapsed Small Cell Lung Cancer
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Completed
Start date
April 14, 2016
Completion date
August 7, 2020
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent small cell lung carcinoma